Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Calum Sutherland

Showing results (1-10 of 81) with videos related to

Pageof 9
Sort By:
International Journal of Alzheimer'S Disease|June 2, 2011
What Are the bona fide GSK3 Substrates?Calum Sutherland
Biochemical Society Transactions|July 27, 2011
Models of dementia: an introductory overviewLindsay Graham, Calum Sutherland
British Journal of Hospital Medicine (London, England : 2005)|December 29, 2018
New developments for prevention of type 1 diabetes: a paradigm shift?Christopher J Schofield, Calum Sutherland
The British Journal of Psychiatry : the Journal of Mental Science|July 3, 2015
Invited commentary on … Lithium treatment and risk for dementia in adults with bipolar disorderCalum Sutherland, Ashleigh C Duthie
Methods in Molecular Biology (Clifton, N.J.)|December 23, 2008
Measuring GSK3 expression and activity in cellsAdam R Cole, Calum Sutherland
BMJ Open|May 12, 2023
Point-of-care testing of HbA1c levels in community settings for people with established diabetes or people at risk of developing type 2 diabetes: a systematic review and meta-analysis protocolAnna Gourlay, Calum Sutherland, Andrew Radley
FEBS Letters|August 14, 2003
Different mechanisms are used by insulin to repress three genes that contain a homologous thymine-rich insulin response elementSatish Patel, Christopher Lipina, Calum Sutherland
Biochemical Pharmacology|May 29, 2012
Insulin resistance in the brain: an old-age or new-age problem?Ritchie Williamson, Alison McNeilly, Calum Sutherland
Primary Care Diabetes|November 4, 2023
Point-of-Care testing of HbA<sub>1</sub>c levels in community settings for people with established diabetes or people at risk of developing diabetes: A systematic review and meta-analysisAnna Gourlay, Calum Sutherland, Andrew Radley
Cell Communication and Signaling : CCS|June 14, 2023
Elraglusib (formerly 9-ING-41) possesses potent anti-lymphoma properties which cannot be attributed to GSK3 inhibitionJosh T Coats, Sudhir Tauro, Calum Sutherland
Pageof 9

Showing results (1-10 of 81) with videos related to

Sort By:
Pageof 9
International Journal of Alzheimer'S Disease|June 2, 2011
What Are the bona fide GSK3 Substrates?Calum Sutherland
Biochemical Society Transactions|July 27, 2011
Models of dementia: an introductory overviewLindsay Graham, Calum Sutherland
British Journal of Hospital Medicine (London, England : 2005)|December 29, 2018
New developments for prevention of type 1 diabetes: a paradigm shift?Christopher J Schofield, Calum Sutherland
The British Journal of Psychiatry : the Journal of Mental Science|July 3, 2015
Invited commentary on … Lithium treatment and risk for dementia in adults with bipolar disorderCalum Sutherland, Ashleigh C Duthie
Methods in Molecular Biology (Clifton, N.J.)|December 23, 2008
Measuring GSK3 expression and activity in cellsAdam R Cole, Calum Sutherland
BMJ Open|May 12, 2023
Point-of-care testing of HbA1c levels in community settings for people with established diabetes or people at risk of developing type 2 diabetes: a systematic review and meta-analysis protocolAnna Gourlay, Calum Sutherland, Andrew Radley
FEBS Letters|August 14, 2003
Different mechanisms are used by insulin to repress three genes that contain a homologous thymine-rich insulin response elementSatish Patel, Christopher Lipina, Calum Sutherland
Biochemical Pharmacology|May 29, 2012
Insulin resistance in the brain: an old-age or new-age problem?Ritchie Williamson, Alison McNeilly, Calum Sutherland
Primary Care Diabetes|November 4, 2023
Point-of-Care testing of HbA<sub>1</sub>c levels in community settings for people with established diabetes or people at risk of developing diabetes: A systematic review and meta-analysisAnna Gourlay, Calum Sutherland, Andrew Radley
Cell Communication and Signaling : CCS|June 14, 2023
Elraglusib (formerly 9-ING-41) possesses potent anti-lymphoma properties which cannot be attributed to GSK3 inhibitionJosh T Coats, Sudhir Tauro, Calum Sutherland
Pageof 9